Literature DB >> 11313880

p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells.

M Sawada1, S Nakashima, T Kiyono, M Nakagawa, J Yamada, H Yamakawa, Y Banno, J Shinoda, Y Nishimura, Y Nozawa, N Sakai.   

Abstract

The present study was designed to elucidate the relationship between p53 and ceramide, both of which are involved in apoptotic signaling. Treatment of human glioma cells with etoposide caused apoptosis only in cells expressing functional p53. p53 activation was followed by the formation of reactive oxygen species (ROS), superoxide anion (O2-*) measured by hydroethidium oxidation into ethidium and hydrogen peroxide (H2O2) measured by oxidation of 2',7'-dichlorofluorescin (DCFH) into 2',7'-dichlorofluorescein (DCF), which was accompanied with ceramide generation through the activation of neutral, but not acid, sphingomyelinase. Superoxide dismutase (SOD), a selective antioxidant for O2-*, had no effects on p53 expression but inhibited ceramide generation and apoptotic cell death caused by etoposide. However, catalase, a specific antioxidant for H2O2, only weakly inhibited and sodium formate, a hydroxyl radical (* OH) scavenger, unaffected etoposide-induced apoptosis. Like etoposide-induced cell death, treatment of glioma cells with the O2-*-releasing agent, pyrogallol, induced typical apoptosis and ceramide generation even in the presence of catalase. In contrast, human glioma cells lacking functional p53, either due to mutation or the expression of E6 protein of human papillomavirus, were highly resistant to etoposide and exhibited no significant change in the ceramide level. Moreover, expression of functional p53 protein in glioma cells expressing mutant p53 using a temperature-sensitive human p53(Val138) induced ceramide accumulation by the activation of neutral sphingomyelinase which was dependent on the generation of O2-*. Taken together, these results suggest that p53 may modulate ceramide generation by activation of neutral sphingomyelinase through the formation of O2-*, but not its downstream compounds H2O2 or * OH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313880     DOI: 10.1038/sj.onc.1204207

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  Induction of apoptosis in glioma cells by molecules released from activated macrophages.

Authors:  George G Chen; Ying S Chu; Ernest C W Chak; Billy C S Leung; Wai S Poon
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

Review 2.  p53 and regulation of bioactive sphingolipids.

Authors:  Linda A Heffernan-Stroud; Lina M Obeid
Journal:  Adv Enzyme Regul       Date:  2010-10-28

Review 3.  Sphingolipids in the DNA damage response.

Authors:  Brittany Carroll; Jane Catalina Donaldson; Lina Obeid
Journal:  Adv Biol Regul       Date:  2014-11-18

Review 4.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

5.  Ceramide induces non-apoptotic cell death in human glioma cells.

Authors:  Wi Hyun Kim; Chang Hwa Choi; Soo Kyung Kang; Chae Hwa Kwon; Yong Keun Kim
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

6.  Reactive oxygen species signaling in cancer: comparison with aging.

Authors:  Igor Afanas'ev
Journal:  Aging Dis       Date:  2010-02-20       Impact factor: 6.745

7.  Ceramide-Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations.

Authors:  Sachin K Khiste; Zhijun Liu; Kartik R Roy; Mohammad B Uddin; Salman B Hosain; Xin Gu; Sami Nazzal; Ronald A Hill; Yong-Yu Liu
Journal:  Mol Cancer Ther       Date:  2019-10-23       Impact factor: 6.261

8.  MAPK inhibitors enhance cell death in pyrogallol-treated human pulmonary fibroblast cells via increasing O2•- levels.

Authors:  Bo Ram Han; Woo Hyun Park
Journal:  Oncol Lett       Date:  2017-05-17       Impact factor: 2.967

9.  Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.

Authors:  Susmita Mondal; Chandan Mandal; Rajender Sangwan; Sarmila Chandra; Chitra Mandal
Journal:  Mol Cancer       Date:  2010-09-13       Impact factor: 27.401

10.  Ceramide and glutathione define two independently regulated pathways of cell death initiated by p53 in Molt-4 leukaemia cells.

Authors:  Wissal El-Assaad; Lina Kozhaya; Sawsan Araysi; Shoghag Panjarian; Fadi F Bitar; Elizabeth Baz; Marwan E El-Sabban; Ghassan S Dbaibo
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.